Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

The Case Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1826-01-01

Employees: 5K

Market Cap: -

Website: http://www.case.edu/cancer

Clinical Trials

ASTX727 and Nivolumab in Squamous Cell Carcinoma of the Head and Neck

Phase 1

Withdrawn

Conditions: Recurrent Squamous Cell Carcinoma of the Head and Neck
Metastatic Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma

Interventions: Drug: INQOVI (decitabine and cedazuridine)
Drug: Nivolumab

First Posted Date: 2024-04-10

Last Posted Date: 2024-07-03

Lead Sponsor: Case Comprehensive Cancer Center

Registration Number: NCT06357858

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Linking Somatic Mutation Rate With Baseline Exposure in East Palestine

Not Applicable

Recruiting

Conditions: Somatic Mutation

Interventions: Other: Survey
Other: Biological specimen collection
Other: Communications about study updates and future research opportunities
Other: Qualitative interview

First Posted Date: 2024-04-10

Last Posted Date: 2024-12-04

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 500

Registration Number: NCT06357845

Locations: 🇺🇸
Case Western Reserve University, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Reiki Therapy to Improve Key Symptoms in Integrative Oncology Clinic (REIKI)

Not Applicable

Recruiting

Conditions: Cancer Pain
Oncology Pain

Interventions: Other: Reiki

First Posted Date: 2024-04-09

Last Posted Date: 2025-01-22

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 20

Registration Number: NCT06354049

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Abbreviated MBCT for Depression in Older African American/Black Breast Cancer Survivors

Not Applicable

Recruiting

Conditions: Moderate Depression
Breast Cancer Female
Breast Cancer Stage I
Breast Cancer
Breast Cancer Stage II
Breast Cancer Stage III
Mild Depression

Interventions: Other: MBCT

First Posted Date: 2024-03-28

Last Posted Date: 2025-05-25

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 31

Registration Number: NCT06336538

Locations: 🇺🇸
Cleveland Clinic Department of Wellness and Preventive Medicine, Cleveland, Ohio, United States

Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy

Phase 2

Not yet recruiting

Conditions: Malignant Neoplasm of Bladder
Muscle Invasive Bladder Carcinoma

Interventions: Drug: Neoadjuvant Chemotherapy
Procedure: Partial cystectomy with Extended pelvic lymph node dissection
Drug: Adjuvant systemic therapy

First Posted Date: 2024-03-04

Last Posted Date: 2025-05-14

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 40

Registration Number: NCT06290687

Locations: 🇺🇸
Glickman Urological and Kidney Institute, Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.

Not Applicable

Recruiting

Conditions: Gastrointestinal Cancer
Anal Cancer
Esophageal Cancer
Appendix Cancer
Liver Cancer
Stomach Cancer
Rectal Cancer
Pancreas Cancer
Colon Cancer
Neuroendocrine Tumors

Interventions: Other: EQUITY GI

First Posted Date: 2024-02-16

Last Posted Date: 2025-05-07

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 200

Registration Number: NCT06263088

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma

Not Applicable

Recruiting

Conditions: Urothelial Carcinoma

Interventions: Procedure: Nephroureterectomy
Procedure: Lymph Node Dissection

First Posted Date: 2024-02-16

Last Posted Date: 2025-07-02

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 94

Registration Number: NCT06262516

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Urology Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
🇺🇸
Cleveland Clinic Glickman Urological and Kidney Institute, Cleveland, Ohio, United States

Effects of Lavender Aromatherapy on Patient Anxiety During Mohs Micrographic Surgery

Not Applicable

Recruiting

Conditions: Skin Cancer
Skin Carcinoma

Interventions: Other: Water
Other: Lavender essential oil

First Posted Date: 2023-12-12

Last Posted Date: 2025-04-24

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 100

Registration Number: NCT06167096

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)

Phase 2

Recruiting

Conditions: Prostate Cancer
Secondary Malignant Neoplasm of Prostate
Malignant Neoplasm of Prostate

Interventions: Drug: Androgen deprivation therapy (ADT)
Drug: Androgen receptor signaling inhibitor (ARSI)
Radiation: Metastasis directed radiotherapy (MDRT)

First Posted Date: 2023-11-29

Last Posted Date: 2025-06-29

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 200

Registration Number: NCT06150417

Locations: 🇺🇸
University Hospitals Cleveland Medical Center Seidman Cancer Center, Cleveland, Ohio, United States

Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast

Phase 2

Recruiting

Conditions: Tumor, Breast
Breast Cancer

Interventions: Radiation: Radiation Therapy

First Posted Date: 2023-11-13

Last Posted Date: 2024-12-13

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 55

Registration Number: NCT06129747

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
🇺🇸
Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy